d-Nav
Commercial- Indications
- Type 2 diabetes
Company intelligence / Profile preview
Hygieia Biotech
Shenzhen, Guangdong, Chinahygieiaph.com ↗
- Ownership
- Public · 1650
- Development stage
- Commercial
01
Overview
Hygieia has commercialized high-purity nicotinamide mononucleotide (NMN) and related coenzyme products using proprietary enzymatic processes. Their NMN has been featured in studies showing potential health benefits, including protection against colon cancer in preclinical models. The company participates in research collaborations to expand applications of their products.
No clinical drug development programs for pharmaceutical approval are reported; focus remains on ingredient supply for supplements with ongoing research into new indications.
- Therapeutic areas
- OtherMetabolic Disorders
- Modalities
- Small moleculeEnzyme
- Industry
- Non-Drug Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with domestic & foreign research institutions for product application expansion
Beyond the preview
Go deeper on Hygieia Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hygieia Biotech.